Devki Sukhtankar, Ph.D. - Publications

2011 Cancer Biology University of Arizona, Tucson, AZ 
pain, opioids, pharmacology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Remeniuk B, King T, Suktankhar D, Nippert A, Li N, Li F, Cheng K, Rice KC, Porreca F. Disease modifying actions of IL-6 blockade in a rat model of bone cancer pain. Pain. PMID 29300279 DOI: 10.1097/j.pain.0000000000001139  0.36
2017 Havelin J, Imbert I, Sukhtankar D, Remeniuk B, Pelletier I, Gentry J, Okun A, Tiutan T, Porreca F, King T. Mediation of movement-induced breakthrough cancer pain by IB4 binding nociceptors in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28438966 DOI: 10.1523/JNEUROSCI.1212-16.2017  0.8
2016 Ding H, Czoty PW, Kiguchi N, Cami-Kobeci G, Sukhtankar DD, Nader MA, Husbands SM, Ko MC. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates. Proceedings of the National Academy of Sciences of the United States of America. PMID 27573832 DOI: 10.1073/pnas.1605295113  0.8
2015 Kiguchi N, Sukhtankar DD, Ding H, Tanaka KI, Kishioka S, Peters CM, Ko MC. Spinal functions of B-type natriuretic peptide, gastrin-releasing peptide, and their cognate receptors for regulating itch in mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 26669425 DOI: 10.1124/jpet.115.229997  0.8
2015 Remeniuk B, Sukhtankar D, Okun A, Navratilova E, Xie JY, King T, Porreca F. Behavioral and Neurochemical Analysis of Ongoing Bone Cancer Pain in Rats. Pain. PMID 25955964 DOI: 10.1097/j.pain.0000000000000218  0.8
2015 Ding H, Hayashida K, Suto T, Sukhtankar DD, Kimura M, Mendenhall V, Ko MC. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates. British Journal of Pharmacology. 172: 3302-12. PMID 25752320 DOI: 10.1111/bph.13124  0.8
2015 Rizzi A, Sukhtankar DD, Ding H, Hayashida K, Ruzza C, Guerrini R, Calò G, Ko MC. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys British Journal of Pharmacology. 172: 3661-3670. DOI: 10.1111/bph.13150  0.8
2014 Sukhtankar DD, Lagorio CH, Ko MC. Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats. European Journal of Pharmacology. 745: 182-9. PMID 25446568 DOI: 10.1016/j.ejphar.2014.10.029  0.8
2014 Sukhtankar DD, Lee H, Rice KC, Ko MC. Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain Psychopharmacology. 231: 1377-1387. PMID 24217900 DOI: 10.1007/s00213-013-3341-0  0.8
2013 Sukhtankar DD, Ko MC. Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. Plos One. 8: e67422. PMID 23826298 DOI: 10.1371/journal.pone.0067422  0.8
2013 Sukhtankar DD, Zaveri NT, Husbands SM, Ko MC. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain. The Journal of Pharmacology and Experimental Therapeutics. 346: 11-22. PMID 23652222 DOI: 10.1124/jpet.113.203984  0.8
2013 Sukhtankar D, Ko MC. Pharmacological investigation of NOP-related ligands as analgesics without abuse liability Acs Symposium Series. 1131: 393-416. DOI: 10.1021/bk-2013-1131.ch018  0.8
2011 Sukhtankar D, Okun A, Chandramouli A, Nelson MA, Vanderah TW, Cress AE, Porreca F, King T. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Molecular Pain. 7: 81. PMID 22014040 DOI: 10.1186/1744-8069-7-81  0.8
Show low-probability matches.